Jerome Galbrun, PhD

Jerome Galbrun, PhD has a diverse work experience spanning different industries and roles. Jerome is currently working as the Global Chief Revenue Officer at BRAINOMIX since 2022. Prior to this, they worked at Philips from 2012 to 2022, holding various positions including Global Business Development Leader, Sr Director Marketing for EMR and Radiology Imaging.

Before their time at Philips, they worked as the Head of Global Business Development at Agfa Healthcare from 2010 to 2012. Jerome also gained valuable experience as a PhD Candidate and Research Assistant at Tokyo Institute of Technology from 2008 to 2010, where they focused on innovation in medical technology and service innovation in healthcare.

Jerome also worked at GE Healthcare where they held multiple roles from 1999 to 2006, including CT Marketing Manager, Six Sigma Master Black Belt, and Sr Finance Analyst. Earlier in their career, they worked at Hewlett-Packard as a Sr Finance Analyst and at Kimberly-Clark as a Marketing & Sales Financial Analyst.

Overall, Jerome Galbrun, PhD has demonstrated their expertise in global business development, marketing, strategic planning, and finance across various industries throughout their career.

Jerome Galbrun, PhD, has a strong educational background with a focus on innovation in medical technology and business administration. Jerome obtained their Master's degree in Business Administration and Management, General from emlyon business school from 1988 to 1991. In 2002, they received an Executive Education certificate in Finance & Marketing from The Wharton School. Later that year, they also completed an Executive Education program at Harvard Business School, specializing in Business Administration and Management, General. Jerome'sacademic journey culminated with a PhD in Innovation in Medical Technology from the Tokyo Institute of Technology, which they completed from 2007 to 2010. In addition to their academic qualifications, Jerome Galbrun also holds a Lean Six Sigma Master Black Belt certification from GE Healthcare, which they obtained in June 2002.